This page is not available in English

Click here to see the Danish page '▼Xeljanz® (tofacitinib): Øget risiko for alvorlige kardiovaskulære hændelser og maligniteter ved brug af tofacitinib sammenlignet med TNF-alfa-hæmmere' Go to English frontpage

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.